|
TAF7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.849800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.808600E-01 |
| Normal-vs-Stage2 |
7.982400E-01 |
| Normal-vs-Stage3 |
2.371200E-01 |
| Normal-vs-Stage4 |
1.652640E-01 |
| Stage1-vs-Stage2 |
7.463600E-01 |
| Stage1-vs-Stage3 |
1.532410E-01 |
| Stage1-vs-Stage4 |
2.295400E-01 |
| Stage2-vs-Stage3 |
4.414600E-01 |
| Stage2-vs-Stage4 |
3.715200E-01 |
| Stage3-vs-Stage4 |
8.307000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.674400E-01 |
| Normal-vs-AfricanAmerican |
7.040200E-01 |
| Normal-vs-Asian |
6.423400E-01 |
| Caucasian-vs-AfricanAmerican |
9.116000E-01 |
| Caucasian-vs-Asian |
8.661800E-01 |
| AfricanAmerican-vs-Asian |
8.187600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.976200E-01 |
| Normal-vs-Female |
2.004400E-01 |
| Male-vs-Female |
1.228350E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.754400E-01 |
| Normal-vs-Extreme_Weight |
5.647200E-01 |
| Normal-vs-Obese |
3.603800E-01 |
| Normal-vs-Extreme_Obese |
2.815800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.510200E-01 |
| Normal_Weight-vs-Obese |
5.409200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.135000E-01 |
| Extreme_Weight-vs-Obese |
7.297600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.853800E-01 |
| Obese-vs-Extreme_Obese |
1.740010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.950200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.654000E-02 |
| Normal-vs-Age(61-80Yrs) |
3.163400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.158200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.703000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.568800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.852800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.414800E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.275200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.001400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.529000E-01 |
| Normal-VS-Type2 PRCC |
7.286200E-01 |
| Normal-VS-KIRP CIMP |
4.290000E-01 |
| Normal-VS-Unclassified PRCC |
8.489800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.830200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.697000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.822000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.714000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.477600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.692600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.352400E-01 |
| Normal-vs-N1 |
3.891900E-02 |
| Normal-vs-N2 |
9.605400E-01 |
| N0-vs-N1 |
4.462300E-03 |
| N0-vs-N2 |
7.849600E-01 |
| N1-vs-N2 |
3.458800E-01 |
|
|
